Li Gen, Sun He, Ye Yangqin, Chen Liqiong, Zhang Wenyan, Yu Shanshan, Li Qiang, Fan Lieying
Department of Clinical Laboratory, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Department of Respiratory and Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Front Cell Infect Microbiol. 2025 Feb 19;15:1469440. doi: 10.3389/fcimb.2025.1469440. eCollection 2025.
Conventional microbial testing (CMTs) for infectious pathogens faces challenges in rapid and comprehensive detection. Nanopore-targeted sequencing (NTS) is a novel approach for rapid identification of pathogens; however, clinical experience with the application of NTS is limited.
We evaluated the diagnostic value of NTS for detecting microbes in bronchoalveolar lavage fluid samples in patients with pulmonary infectious disease (PID, 137 cases), non-pulmonary infectious disease (NPID, 32 cases), or with an unknown etiology (11 cases). We performed a comparative analysis of the diagnostic efficacy of NTS and CMTs in identifying pulmonary infectious diseases and investigated the clinical utility of NTS as a diagnostic tool.
NTS was significantly more sensitive than CMTs in detecting PID (86.13% vs 67.15%, P < 0.01), particularly for important specific pathogens. There were no significant differences between NTS and CMTs in terms of specificity, positive predictive value or negative predictive value. Moreover, NTS (not CMTs) detected 56 microorganisms consistent with clinical presentation, indicating that NTS can provide clinicians with additional support for infection diagnosis. Additionally, prior antibiotic exposure had no influence on the detection efficiency of NTS but significantly hindered that of CMTs. After antibiotic adjustments based on NTS findings, 87.76% of patients showed significant improvement, with a notable decrease in the level of inflammatory markers (CRP, NP, PCT, WBC) post-treatment. Furthermore, NTS can significantly shorten turnaround time and provide real-time results for rapid decision making.
NTS is more efficient than CMTs in diagnosing pulmonary infectious diseases, particularly in detecting critical or specific pathogens, providing faster and more accurate clinical information even for patients with prior antibiotic exposure. Moreover, NTS can assist clinicians in formulating more effective anti-infection strategies.
针对感染性病原体的传统微生物检测(CMTs)在快速、全面检测方面面临挑战。纳米孔靶向测序(NTS)是一种快速鉴定病原体的新方法;然而,NTS应用的临床经验有限。
我们评估了NTS在检测肺部感染性疾病(PID,137例)、非肺部感染性疾病(NPID,32例)或病因不明(11例)患者的支气管肺泡灌洗 fluid 样本中的微生物的诊断价值。我们对NTS和CMTs在识别肺部感染性疾病中的诊断效能进行了比较分析,并研究了NTS作为诊断工具的临床实用性。
NTS在检测PID方面比CMTs显著更敏感(86.13%对67.15%,P<0.01),特别是对于重要的特定病原体。NTS和CMTs在特异性、阳性预测值或阴性预测值方面没有显著差异。此外,NTS(而非CMTs)检测到56种与临床表现一致的微生物,表明NTS可以为临床医生提供感染诊断的额外支持。此外,先前的抗生素暴露对NTS的检测效率没有影响,但显著阻碍了CMTs的检测效率。根据NTS结果调整抗生素后,87.76%的患者显示出显著改善,治疗后炎症标志物(CRP、NP、PCT、WBC)水平显著下降。此外,NTS可以显著缩短周转时间并提供实时结果以进行快速决策。
NTS在诊断肺部感染性疾病方面比CMTs更有效,特别是在检测关键或特定病原体方面,即使对于先前接受过抗生素治疗的患者也能提供更快、更准确的临床信息。此外,NTS可以帮助临床医生制定更有效的抗感染策略。